In August, the College hosted its first annual In Vivo Predictive Dissolution Conference, bringing together experts from around the globe with representatives from academia, industry, and government in the fields of clinical science, engineering and basic science. This wide-ranging group of thought leaders presented on the state of current research in biopredictive dissolution science and methodology.
Dr. Karen Farris, Charles R. Walgreen III Professor of Pharmacy Administration, received funding in April 2014 from the Agency for Healthcare Research and Quality for an innovative text messaging research project.
In the June 26, 2014 issue of Nature, Dr. David Sherman, and collaborators have taken a major stride forward in understanding how the biochemical ‘machinery’ in microbes containing the step-by-step blueprints for natural product synthesis is operating.
Last September, the U.S. Food and Drug Administration (FDA) awarded $4.8 million in project funding to the University of Michigan College of Pharmacy encompassing every department at the College. This success affirmed our faculty’s scientific standing and our interest in having our research translated into drug product efficacy, safety, and quality.
In its December 2013 issue, The Scientist magazine named a product derived from a discovery in the research laboratory of Ronald W. Woodard, PhD, as one of the Top 10 Innovations for 2013. The selection was made by a six-person panel of scientific and business leaders recruited by The Scientist magazine.
Steve Schwendeman, PhD, remembers when his father, also an academic, was coming up through the ranks. “Back then, it was important to show how independent you were so there was a disincentive for some scientists to seek out potential collaborators,” says the Ara G. Paul Professor and Chair of Department of Pharmaceutical Sciences.